Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Podcasts
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
Animal Models
Drugs in Trials
SchizophreniaGene
Research Tools
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Note: We have included some relevant news stories written for our partner site, the Alzheimer Research Forum
Search Research News
Search by keyword or publication date

SEARCH KEYWORDS:   
SEARCH FROM: 
TO:   
Browse Research News
1 to 25 of 961 results
What's in a Name? New Nomenclature for Psychoactive Drugs Hopes to Bring Clarity to Prescribing
17 June 2016. A task force is advocating a new system of naming psychoactive drugs that will replace traditional indication-based names....


Parental Age and Risk of Mental Illness: More Than Mutations
7 June 2016. The relationship between parental age and risk for common mental disorders such as schizophrenia and autism has captured a great deal of attention...

  
News Brief: Athina Markou Dies
25 May 2016. The psychiatric research community will be saddened to learn that Athina Markou died on May 18....


New Genes of Interest, AS3MT and BORCS7, for Schizophrenia
12 May 2016. Transcripts in the brain have identified likely risk genes for schizophrenia along chromosome 10....


Searching for the Elusive Epigenetic Influence on Schizophrenia
11 May 2016. Two studies of DNA methylation offer more evidence that the way genes are turned on and off could be a source of risk for schizophrenia....

  
Bumpy Launch for New Clozapine Monitoring Program
11 May 2016. Last fall, the U.S. FDA implemented major changes to regulations governing the use of the antipsychotic medication clozapine....

  
CRISPR Verifies Risk Alleles, Improves Gene Editing
10 May 2016. New versions of the CRISPR/Cas9 gene-editing system allow researchers to alter the eukaryotic genome more precisely and efficiently than ever before...


News Brief: US FDA Approves Pimavanserin for Parkinson Psychosis
5 May 2016. The US Food and Drug Administration has approved pimavanserin for the relief of the psychosis symptoms that occur in about 50 percent of people with Parkinson's disease


Deviation From Family Cognitive Aptitude May Help Predict Schizophrenia Risk
19 April 2016. A new study shows a person's poor cognitive performance relative to his or her family members is associated with a higher risk of developing schizophrenia....


FDA Advisory Committee Recommends Pimavanserin for Parkinson's Disease Psychosis
19 April 2016. An FDA advisory committee recommended that pimavanserin (trade name Nuplazid®) be approved for treating Parkinson's disease psychosis...


SIRS 2016—Of Vitamin D, Critical Periods, and Clinical Trials
14 April 2016. John McGrath of Queensland Brain Institute in Brisbane, Australia, deftly bridged the gap between epidemiology and neuroscience....


SIRS 2016—Tracing Trajectories in Longitudinal Studies
13 April 2016. Plenary speaker Raquel Gur argued that getting a better idea of the earliest stages of risk for mental illness is essential for precision medicine....


SIRS 2016—Subtyping Schizophrenia
8 April 2016. Considering the heterogeneity of schizophrenia, researchers have been looking for signs beyond symptoms that may divide the diagnosis into more homogeneous subgroups...


SIRS 2016—A New Day for Dopamine?
5 April 2016. The study of dopamine dysfunction, once the dominant theme in schizophrenia research, has faded a bit in recent years...


SIRS 2016—Florence Warmly Welcomes Schizophrenia Researchers
4 April 2016. The Fifth Schizophrenia International Research Society (SIRS) conference got underway in balmy Florence, Italy, on Saturday evening, April 2....


Encenicline Misses Endpoints in Two Phase 3 Schizophrenia Trials
29 March 2016. FORUM Pharmaceuticals announced topline results yesterday of its experimental drug encenicline...


Studies Converge on SETD1A as Schizophrenia Risk Gene
23 March 2016. Two studies have converged on the same gene, SETD1A, as a major risk factor for schizophrenia....


Molecular Magneto: Protein Opens Neuronal Ion Channel as Commanded by Magnetic Field
22 March 2016. Scientists have invented a protein, Magneto (of X-Men fame), that allows them to use a magnetic field to control the firing of neurons...


New Study Finds Schizophrenia Risk Gene TCF4 Regulates Neuronal Excitability
16 March 2016. A new study provides insights into how a schizophrenia risk gene regulates the excitability of neurons in the rodent prefrontal cortex...

  
News Brief: NIMH Budget and Director Search
9 March 2016. There is such a thing as good budget news...


New Study Shows Nonrandom Mating in People With Psychiatric Disorders
4 March 2016. Results from a new study show that people with psychiatric disorders pair with partners who also have a psychiatric disorder more frequently than would be expected by chance...

  
Deletion Model Adds to Understanding of Genes-to-Behavior Pathways
26 February 2016. Two papers highlight the power of the 22q11.2 deletion mouse model to reveal the genetic and molecular underpinnings of these diverse impairments...

  
New Compounds May Help Probe the Glutamate Hypothesis of Schizophrenia
19 February 2016. Newly discovered compounds that can modulate particular NMDA receptors may help researchers explore the etiology of schizophrenia...

  
Early Psychosis Research Matures, Going Both Deep and Wide
15 February 2016. The turmoil of a first psychotic episode suggests major changes in brain function, yet the beginnings of a break from reality remain mysterious...


Genetic Variants Tied to Lithium Response in Bipolar Disorder
15 February 2016. In a large GWAS of drug response in a psychiatric disease, investigators have identified variants connected with the therapeutic effects of lithium in bipolar disorder...


1 to 25 of 961 results

Check out our latest webinar, The Baby and the Bathwater: Signal and Noise in Psychiatric Neuroimaging.

See our recent webinar, Social Cognition in Schizophrenia.
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright